ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 32 filers reported holding ATYR PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | -75.0% | 1,397 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | -20.0% | 1,397 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | +66.7% | 1,397 | +86.5% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 749 | -6.3% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 799 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 799 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 799 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -77.8% | 799 | -57.2% | 0.00% | – |
| Q1 2016 | $9,000 | +12.5% | 1,865 | +133.4% | 0.00% | – |
| Q4 2015 | $8,000 | 0.0% | 799 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | -46.7% | 799 | 0.0% | 0.00% | – |
| Q2 2015 | $15,000 | – | 799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $1,485,000 | 0.74% |
| Artal Group S.A. | 500,000 | $406,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 94,466 | $77,000 | 0.01% |
| VIKING GLOBAL INVESTORS LP | 1,384,300 | $1,125,000 | 0.01% |
| Glen Harbor Capital Management LLC | 153,238 | $125,000 | 0.00% |
| Tyers Asset Management LLC | 72,112 | $59,000 | 0.00% |
| Elkfork Partners LLC | 99,154 | $81,000 | 0.00% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $65,000 | 0.00% |
| A.R.T. Advisors, LLC | 43,316 | $35,000 | 0.00% |
| Meadow Creek Investment Management LLC | 126,196 | $103,000 | 0.00% |